HOXA5 anticorps (AA 201-270) (Alexa Fluor 488)

N° du produit ABIN901093

Détail du produit anti-HOXA5 anticorps (Alexa Fluor 488)

Antigène: HOXA5 (Homeobox A5 (HOXA5))

Épitope: AA 201-270

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp HOXA5 est conjugé à/à la Alexa Fluor 488

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Cow,Sheep,Pig,Horse,Chicken,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human HOXA5

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur HOXA5

Antigène: HOXA5 (Homeobox A5 (HOXA5))

Autre désignation: HOXA5 (HOXA5 Produits)

Synonymes: anticorps HOX1, anticorps HOX1.3, anticorps HOX1C, anticorps Hox-1.3, anticorps HOXA5, anticorps hox1, anticorps hox1c, anticorps hox1.3, anticorps Hoxa-5, anticorps homeobox A5, anticorps homeobox protein Hox-A5, anticorps homeo box A5, anticorps hoxa5a protein, anticorps HOXA5, anticorps Hoxa5, anticorps LOC463310, anticorps hoxa5, anticorps hoxa5a

Sujet:

Synonyms: Homeo box 1C antibody Homeobox A5 antibody Homeobox protein HOXA5 antibody HOX 1 antibody HOX 1.3 antibody HOX 1C antibody HOX1 antibody HOX1.3 antibody HOX1C antibody, HXA5_HUMAN.

Background: HOXA5 upregulates both p53 promoter-reporter constructs and endogenous p53 synthesis, leading to apoptosis. HOXA5 is detectable in approximately one-third of primary tumors. Lack of HOXA5 expression strongly correlates with methylation of its promoter region, suggesting a causal role for methylation in the silencing of HOXA5 gene expression. HOXA5 expression is an important step in tumorigenesis and loss of expression of p53 in human breast cancer may be primarily due to lack of expression of HOXA5.

ID gène: 3202